Barclays Capital Gives Overweight Rating to Magellan Health Services (MGLN)

By admin | 7 years ago

Magellan Health Services (NASDAQ: MGLN)‘s stock had its “overweight” rating reiterated by investment analysts at Barclays Capital (NYSE: BCS) in a note issued to investors on Monday.

Magellan Health Services traded down 0.97% on Monday, hitting $43.85. Magellan Health Services has a 1-year low of $41.10 and a 1-year high of $56.76. The company has a market cap of $1.192 billion and a price-to-earnings ratio of 11.29.

The company last announced its quarterly results on Friday, April 27th. It reported $0.75 earnings per share (EPS) for the previous quarter, missing the Thomson Reuters consensus estimate of $0.90 EPS by $0.15. The company’s quarterly revenue was up 11.6% on a year-over-year basis. On average, analysts predict that Magellan Health Services will post $1.04 earnings per share next quarter.

Magellan Health Services, Inc. (Magellan) is engaged in the specialty managed healthcare business. The Company provides services to health plans, insurance companies, employers, labor unions and various governmental agencies.

About the author